Treatment for MRSA Paronychia
For MRSA paronychia, perform incision and drainage as the primary treatment, followed by oral antibiotics with clindamycin, trimethoprim-sulfamethoxazole (TMP-SMX), or doxycycline/minocycline for 5-10 days. 1
Treatment Algorithm
Step 1: Drainage First
Paronychia represents a localized abscess/purulent collection around the nail fold. Incision and drainage is the cornerstone of treatment and should be performed immediately 1. This may involve:
- Lifting the nail fold to drain pus
- Partial or complete nail removal if infection extends under the nail plate
- Ensuring adequate drainage of all purulent material
Step 2: Determine Need for Antibiotics
Antibiotics are indicated when paronychia is associated with 1:
- Extensive disease or rapid progression
- Associated cellulitis spreading beyond the immediate nail fold
- Systemic signs (fever, elevated WBC, tachycardia)
- Location on hand (difficult to drain area)
- Immunosuppression or comorbidities
- Lack of response to drainage alone
Step 3: Antibiotic Selection for Outpatient MRSA Coverage
First-line oral options (choose one) 1:
- Clindamycin 300-450 mg PO three times daily
- TMP-SMX (double-strength) 1-2 tablets PO twice daily
- Doxycycline or minocycline 100 mg PO twice daily
Duration: 5-10 days based on clinical response 1
Step 4: When to Hospitalize
Consider IV antibiotics and admission if 1:
- Failed outpatient oral therapy
- Systemic toxicity (temperature >38°C, HR >90, RR >24, WBC >12,000 or <4,000)
- Deep tissue involvement (tenosynovitis, osteomyelitis)
- Immunocompromised state
IV options for severe cases 1:
- Vancomycin 15-20 mg/kg IV every 8-12 hours
- Linezolid 600 mg IV/PO twice daily
- Daptomycin 4 mg/kg IV once daily
- Clindamycin 600 mg IV three times daily (if local resistance <10%)
Critical Considerations
Culture is essential 1: Obtain culture from purulent drainage to confirm MRSA and guide therapy, especially if systemic antibiotics are used or if the patient fails initial treatment.
Avoid rifampin monotherapy 1: Do not use rifampin alone or as adjunctive therapy for skin and soft tissue infections.
Pediatric modifications 1:
- Avoid tetracyclines in children <8 years old
- Use clindamycin 10-13 mg/kg/dose every 6-8 hours
- Linezolid 10 mg/kg every 8 hours for children <12 years
Common Pitfalls
Antibiotics without drainage will fail 1: The most common error is prescribing antibiotics without adequate surgical drainage. Purulent collections require physical drainage—antibiotics alone are insufficient.
Recurrence risk 2: MRSA paronychia can recur, particularly in families with colonization. Consider decolonization protocols (mupirocin nasal ointment, chlorhexidine body washes) if recurrent infections occur 1, 2.
Chronic paronychia is different 3: If the paronychia is chronic (>6 weeks), consider non-infectious etiologies like contact dermatitis or fungal colonization rather than bacterial infection. Systemic antibiotics are often ineffective in chronic cases unless acute bacterial superinfection is proven.
Watch for complications 4: Though rare, MRSA paronychia can lead to serious complications including pyomyositis, osteomyelitis, or bacteremia, particularly in immunocompromised patients. Maintain high suspicion if fever persists or systemic symptoms develop.